Jul 01, 2009
23:20
For every 20 shares held, investors received 23. The price per share adjusted from $67.00 to $58.26.
The split itself did not change the total investment value.
Apex Biotechnology Corp. (TWSE:1733) operates in the Biotechnology industry.
Apex Biotechnology Corp. company overviewApex Biotechnology Corp.'s most recent stock split was on July 1, 2009. It was a 23-for-20 forward split, so shareholders received 23 shares for every 20 they held.
Apex Biotechnology Corp. (TWSE:1733) has split its stock 6 times: a 131-for-100 split on August 9, 2001, a 131-for-100 split on July 4, 2002, a 581-for-500 split on July 14, 2004, a 859-for-834 split on June 14, 2006, a 11-for-10 split on July 19, 2007, and a 23-for-20 split on July 1, 2009.
Apex Biotechnology Corp. has split its stock 6 times. This history records 6 forward splits between August 9, 2001 and July 1, 2009.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Apex Biotechnology Corp.'s 23-for-20 split on July 1, 2009, every 20 shares became 23 shares.
Apex Biotechnology Corp. has not announced a new split in our records. Its most recent split was on July 1, 2009, 17 years ago. Companies announce splits in advance, and any new TWSE:1733 split will appear on this page.
Already premium?